Managing Chronic Severe Hypertension in Pregnancy

Handler, Joel

doi:10.1111/j.1524-6175.2006.05148.x

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some athletes benefit from β‐blockade, but these agents are banned in certain precision sports. Older agents such as alpha‐methyldopa are rarely needed 40,41 …”

Section: Treatment Of the Hypertensive Athletementioning

confidence: 99%

Hypertension in Athletes

Leddy¹,

Izzo

2009

J of Clinical Hypertension

View full text Add to dashboard Cite

Regular physical activity and training are associated with reductions in blood pressure (BP), yet elevated BP is one of the most common abnormalities found during the pre‐participation physical evaluation of athletes. Hypertension (HTN) remains the most common cardiovascular condition encountered in athletic populations, therefore all athletes require screening for HTN. Because athletes often have white coat HTN, BP recordings outside the office are also necessary. The 36th Bethesda Conference classified sports according to their varying physiologic demands and provided specific recommendations for the evaluation, treatment, and sport participation of athletes with HTN. In general, angiotensin‐converting enzyme inhibitors and other vasodilators are the medications of choice for active and athletic patients because of their limited interference with cardiovascular conditioning. Other agents can be used but some sports governing bodies proscribe the use of certain antihypertensive medications such as β‐blockers for elite athletes.

show abstract

“…Some athletes benefit from β‐blockade, but these agents are banned in certain precision sports. Older agents such as alpha‐methyldopa are rarely needed 40,41 …”

Section: Treatment Of the Hypertensive Athletementioning

confidence: 99%

Hypertension in Athletes

Leddy¹,

Izzo

2009

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…Furthermore, women with advanced chronic kidney disease (stage 4-5) prior to pregnancy have an increased risk of an accelerated decline in renal function, potentially leading to end-stage disease and the need for renal replacement therapy either in pregnancy or shortly after 75 . Other relative contraindications to pregnancy in patients with inflammatory rheumatic diseases that require multidisciplinary consultation and management include pulmonary hypertension 76 , severe interstitial lung disease 77 , advanced heart failure 78 and previous severe gestational hypertensive disorders despite therapy 79 .…”

Section: [H2] Presence Of Organ Dysfunctionmentioning

confidence: 99%

Stratifying management of rheumatic disease for pregnancy and breastfeeding

2019

View full text Add to dashboard Cite

The management of inflammatory rheumatic diseases during pregnancy and breastfeeding has undergone considerable change in the past few years. Modern therapeutics, including biologic and targeted synthetic DMARDs, have enabled substantial improvements in control of rheumatic diseases, resulting in more patients with severe disease considering pregnancy. Therefore, management of disease for these patients needs to be discussed with clinicians before, during and after pregnancy and patients need to know what complications they might experience before they become pregnant. This Review will summarize the effects pregnancy has on various rheumatic diseases and the effects these diseases have on pregnancy, as well as provide advice regarding the alteration and monitoring of therapy before, during and after pregnancy. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

show abstract

Managing Chronic Severe Hypertension in Pregnancy

Cited by 2 publications

References 17 publications

Hypertension in Athletes

Hypertension in Athletes

Stratifying management of rheumatic disease for pregnancy and breastfeeding

Contact Info

Product

Resources

About